文献速递前列腺癌

前列腺特异性膜抗原正电子发射断层显像/计算机断层显像对磁共振成像在前列腺癌根治性前列腺切除术前局部分期中的附加价值

The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy.
PubMed 文献 · Eur Urol Oncol · 2024-11-29

多中心回顾性研究纳入550例根治性前列腺切除术前接受PSMA PET/CT与MRI的前列腺癌患者,病理证实52%有前列腺外侵犯、21%有精囊侵犯。MRI对前列腺外侵犯的敏感度高于PSMA PET/CT(60% vs 41%,p<0.001),但两者联合较单用MRI提高前列腺外侵犯和精囊侵犯的敏感度。

要点

  • MRI对前列腺外侵犯的敏感度高于PSMA PET/CT(60% vs 41%,p<0.001)。
  • PSMA PET/CT与MRI联合较单用MRI提高前列腺外侵犯敏感度至73%(p<0.001)。
  • 联合较单用MRI提高精囊侵犯敏感度至60%(p<0.001)和AUC至76%(p<0.001)。

核心结论

  • PSMA PET/CT对前列腺外侵犯的敏感度低于MRI,但将PSMA PET信息加入MRI可提高前列腺外侵犯和精囊侵犯的检出敏感度,两种模态应联合用于指导治疗选择。

研究设计与样本

  • 多中心回顾性研究,纳入根治性前列腺切除术前接受PSMA PET/CT和MRI的患者550例,其中低危2%、中危43%、高危55%。

主要发现

  • 病理证实在52%患者中存在前列腺外侵犯、21%存在精囊侵犯。
  • 基于患者的前列腺外侵犯检出比较,MRI vs PSMA PET/CT:敏感度60% vs 41%(p<0.001),特异度77% vs 83%(p=0.075),阳性预测值75% vs 73%(p=0.6),阴性预测值64% vs 56%(p<0.001),AUC 69% vs 62%(p=0.01)。
  • 联合两种模态较单用MRI提高前列腺外侵犯检出的敏感度(73%,p<0.001)和阴性预测值(69%,p<0.001),降低特异度(67%,p<0.001)和阳性预测值(71%,p=0.01)。
  • 基于患者的精囊侵犯检出比较,MRI vs PSMA PET/CT:敏感度36% vs 44%(p=0.2),特异度96% vs 96%(p>0.99),阳性预测值71% vs 75%(p=0.6),阴性预测值85% vs 87%(p=0.2),AUC 66% vs 70%(p=0.2)。
  • 联合两种模态较单用MRI提高精囊侵犯检出的敏感度(60%,p<0.001)、阴性预测值(90%,p<0.001)和AUC(76%,p<0.001),降低特异度(92%,p<0.001)。

临床怎么用

  • 作者认为,两种模态应联合用于指导治疗选择。

局限性

  • 研究为回顾性性质。
  • PSMA PET/CT的选择偏向较高危病例。
  • 缺乏中心化审阅。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The role of prostate-specific membrane antigen (PSMA)-based positron emission tomography (PET)/computed tomography (CT) in addition to magnetic resonance imaging (MRI) for local staging of prostate cancer (PC) has been poorly addressed so far. Our aim was to assess the diagnostic accuracy of PSMA PET/CT and MRI, alone and combined, for detection of extraprostatic extension (EPE) and seminal vesicle invasion (SVI) in PC. METHODS: We conducted a multicenter retrospective study evaluating patients undergoing PSMA PET/CT and MRI before radical prostatectomy. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUC) for detection of EPE and SVI were calculated for MRI and PSMA PET/CT alone and combined. KEY FINDINGS AND LIMITATIONS: We included 550 patients, of whom 2%, had low-risk, 43% had intermediate-risk, and 55% had high-risk PC. Overall, 52% of patients had EPE and 21% had SVI at histopathology. Patient-based comparison of MRI versus PSMA PET/CT for detection of EPE revealed sensitivity of 60% versus 41% (p < 0.001), specificity of 77% versus 83% (p = 0.075), PPV of 75% versus 73% (p = 0.6), NPV of 64% versus 56% (p < 0.001), and AUC of 69% versus 62% (p = 0.01). Combining the modalities increased the sensitivity (73%; p < 0.001) and NPV (69%; p < 0.001) and decreased the specificity (67%; p < 0.001) and PPV (71%; p = 0.01) over MRI alone. Patient-based comparison of MRI versus PSMA PET/CT for detection of SVI revealed sensitivity of 36% versus 44% (p = 0.2), specificity of 96% versus 96% (p > 0.99), PPV of 71% versus 75% (p = 0.6), NPV of 85% versus 87% (p = 0.2), and AUC of 66% versus 70% (p = 0.2). Combining the modalities increased the sensitivity (60%; p < 0.001), NPV (90%; p < 0.001), and AUC (76%; p < 0.001) and decreased the specificity (92%; p < 0.001) over MRI alone. Limitations include the retrospective nature of the study, selection of higher-risk cases for PSMA PET/CT, and lack of central review. CONCLUSIONS AND CLINICAL IMPLICATIONS: PSMA PET/CT has lower sensitivity for EPE detection in comparison to MRI. However, addition of PSMA PET information to MRI improved the sensitivity for EPE and SVI detection. Thus, the two modalities should be combined to guide treatment selection. PATIENT SUMMARY: Combining MRI (magnetic resonance imaging) scans with another type of imaging called PSMA PET/CT (prostate-specific membrane antigen positron emission tomography/computed tomography) for patients with prostate cancer leads to better identification of cancer growth outside the prostate in comparison to MRI alone. This could potentially improve the choice of prostate cancer treatment.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Soeterik TFW, Heetman JG, Hermsen R, et al. The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy. Eur Urol Oncol. 2024. PMID: 39613565. doi:10.1016/j.euo.2024.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。